EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents

Tobias Winge, Ben Perry, An Matheeussen, Guy Caljon, Bernhard Wünsch iD

ChemMedChem · 16.04.2024 · 19 (8)

DOI: 10.1002/cmdc.202400028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 16.02.2024. Verfasst von Tobias Winge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Corrensstraße 48, D-48149, Münster, Germany. Hauptthemen laut MEDLINE: Antiprotozoal Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N ‐Pyrazolylcarboxamides and N ‐pyrazolylureas represent promising lead compounds for the development of novel antileishmanial drugs. Herein, we report the late‐stage diversification of 3‐bromopyrazoles 10 A / B and 14 A by Pd‐catalyzed Sonogashira and Suzuki‐Miyaura cross coupling reactions. The electron‐withdrawing properties of the cyano moiety in 4‐position of the pyrazole ring limited the acylation of the primary amino moiety in 5‐position. A large set of pyrazoles bearing diverse aryl and alkynyl substituents in 3‐position was prepared and the antileishmanial and antitrypanosomal activity was recorded. The urea 38 lacking the electron withdrawing cyano moiety in 4‐position and containing the large 4‐benzylpiperidinoo moiety exhibited a modest antileishmanial ( IC 50 =19 μM) and antitrypanosomal activity ( IC 50 =7.9 μM)). However, its considerable toxicity against the PMM and MRC‐5 cells indicates low selectivity, i. e . a small gap between the desired antiparasitic activity and undesired cytotoxicity of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsAntiparasitic AgentsPyrazoles

Stichwörter der Autor:innen

3-arylpyrazolesDrugs for Neglected Diseases initiative (DNDi)Sonogashira cross couplingSuzuki-Miyaura cross couplingantileishmanial activityantitrypanosomal activitybromopyrazoleslate stage diversificationopen synthesis network (OSN)

Substanzen

Antiprotozoal AgentsAntiparasitic AgentsPyrazoles

Autor:innen und Institutionen

  • Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Corrensstraße 48, D-48149, Münster, Germany.
  • Drugs for Neglected Diseases initiative, 15 chemin Camille-Vidart, 1202, Geneva, Switzerland.
  • current Address: Medicxi Ventures, 10 Cours de Rive, 1204, Geneva, Switzerland.
  • University of Antwerpen, Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Infla-Med Centre of Excellence, Campus CDE, S7.24, Universiteitsplein 1 B, 2610 Wilrijk-, Antwerpen.
  • GRK 2515, Chemical biology of ion channels (Chembion), Universität Münster, Corrensstr. 48, D-48149, Münster, Germany.

ORCID-Profile: Bernhard Wünsch

Zitieren

APA

Winge, T., Perry, B., Matheeussen, A., Caljon, G., & Wünsch, B. (2024). Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents. ChemMedChem, 19(8). https://doi.org/10.1002/cmdc.202400028

Vancouver

Winge T, Perry B, Matheeussen A, Caljon G, Wünsch B. Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents. ChemMedChem. 2024;19(8). doi:10.1002/cmdc.202400028

BibTeX
@article{Winge2024,
  author = {Winge, Tobias and Perry, Ben and Matheeussen, An and Caljon, Guy and Wünsch, Bernhard},
  title = {Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents},
  journal = {ChemMedChem},
  year = {2024},
  volume = {19},
  number = {8},
  doi = {10.1002/cmdc.202400028}
}
Kostenlos starten →